270 related articles for article (PubMed ID: 34483928)
1. The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications.
Solly EL; Psaltis PJ; Bursill CA; Tan JTM
Front Pharmacol; 2021; 12():718679. PubMed ID: 34483928
[TBL] [Abstract][Full Text] [Related]
2. Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people.
Morrison KR; Solly EL; Shemesh T; Psaltis PJ; Nicholls SJ; Brown A; Bursill CA; Tan JTM
Diabetologia; 2021 Jun; 64(6):1402-1411. PubMed ID: 33651121
[TBL] [Abstract][Full Text] [Related]
3. The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis.
Hourigan ST; Solly EL; Nankivell VA; Ridiandries A; Weimann BM; Henriquez R; Tepper ER; Zhang JQJ; Tsatralis T; Clayton ZE; Vanags LZ; Robertson S; Nicholls SJ; Ng MKC; Bursill CA; Tan JTM
Sci Rep; 2018 Sep; 8(1):13596. PubMed ID: 30206364
[TBL] [Abstract][Full Text] [Related]
4. miR-181c-3p and -5p promotes high-glucose-induced dysfunction in human umbilical vein endothelial cells by regulating leukemia inhibitory factor.
Shen X; Li Y; Sun G; Guo D; Bai X
Int J Biol Macromol; 2018 Aug; 115():509-517. PubMed ID: 29605252
[TBL] [Abstract][Full Text] [Related]
5. MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1.
Yang G; Wu Y; Ye S
Biochem Biophys Res Commun; 2017 Apr; 486(1):29-35. PubMed ID: 28223216
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of bone mesenchymal stem cells with miR181-c facilitates craniofacial defect reconstruction via activating AMPK-Mfn1 signaling pathways.
Fan L; Wang J; Ma C
J Recept Signal Transduct Res; 2019 Jun; 39(3):199-207. PubMed ID: 31466503
[No Abstract] [Full Text] [Related]
7. miR125a attenuates BMSCs apoptosis via the MAPK-ERK pathways in the setting of craniofacial defect reconstruction.
Fan L; Wang J; Ma C
J Cell Physiol; 2020 Mar; 235(3):2857-2865. PubMed ID: 31578723
[TBL] [Abstract][Full Text] [Related]
8. The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis.
Primer KR; Psaltis PJ; Tan JTM; Bursill CA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455604
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.
Reddy MA; Das S; Zhuo C; Jin W; Wang M; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):864-73. PubMed ID: 26941017
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in vascular diseases, inflammation, and angiogenesis.
Urbich C; Kuehbacher A; Dimmeler S
Cardiovasc Res; 2008 Sep; 79(4):581-8. PubMed ID: 18550634
[TBL] [Abstract][Full Text] [Related]
11. Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin.
Arunachalam G; Lakshmanan AP; Samuel SM; Triggle CR; Ding H
J Pharmacol Exp Ther; 2016 Feb; 356(2):314-23. PubMed ID: 26582729
[TBL] [Abstract][Full Text] [Related]
12. Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.
Chen L; Okeke E; Ayalew D; Wang D; Shahid L; Dokun AO
Exp Biol Med (Maywood); 2017 Aug; 242(14):1432-1443. PubMed ID: 28637396
[TBL] [Abstract][Full Text] [Related]
13. miR-126 as a Therapeutic Agent for Diabetes Mellitus.
Pishavar E; Behravan J
Curr Pharm Des; 2017; 23(22):3309-3314. PubMed ID: 28440196
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects.
Fadini GP; Albiero M; Bonora BM; Avogaro A
J Clin Endocrinol Metab; 2019 Nov; 104(11):5431-5444. PubMed ID: 31211371
[TBL] [Abstract][Full Text] [Related]
16. miR-24 suppression of POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) protects endothelial cell from diabetic damage.
Cui YX; Hua YZ; Wang N; Chen X; Wang F; Liu JY; Wang LL; Yan CY; Ma YG; Cao YH; Zhang XH
Biochem Biophys Res Commun; 2016 Nov; 480(4):682-689. PubMed ID: 27983982
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ; Chew GT; Watts GF
Drugs; 2005; 65(1):31-74. PubMed ID: 15610050
[TBL] [Abstract][Full Text] [Related]
18. Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a.
Icli B; Nabzdyk CS; Lujan-Hernandez J; Cahill M; Auster ME; Wara AK; Sun X; Ozdemir D; Giatsidis G; Orgill DP; Feinberg MW
J Mol Cell Cardiol; 2016 Feb; 91():151-9. PubMed ID: 26776318
[TBL] [Abstract][Full Text] [Related]
19. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
